Posts by Max Garduño:

• CNCM is awarded $1.4 million NIH grant for Alzheimer’s disease research training Posted on June 13, 2024 (June 13, 2024) by Max Garduño in Uncategorized
• UCI research on the degu Alzheimer’s disease model featured in The Transmitter Posted on June 2, 2024 (June 2, 2024) by Max Garduño in Uncategorized
• UCI-led study shows cognitively impaired degu is a natural animal model well suited for Alzheimer’s research Posted on December 19, 2022 (December 19, 2022) by Max Garduño in Uncategorized
• CNCM Members Recognized in Irvine Standard’s “10 leaders at the center of Irvine’s health care” Posted on December 6, 2022 (December 6, 2022) by Max Garduño in Uncategorized
• CNCM Cajal Conference August 20 – Register Now! Posted on July 14, 2021 (July 14, 2021) by Max Garduño in Uncategorized
• UCI-led 4D Nucleome project receives $3 million from NIH to map aging-associated chromatin organizational changes in human brain cells Posted on October 15, 2020 (October 13, 2020) by Max Garduño in Uncategorized
• New study finds antidepressant drug effective in treating “lazy eye” in adults Posted on September 25, 2020 (July 14, 2021) by Max Garduño in Uncategorized
• CNCM leaders publish new guide for viral tracers in neural circuit mapping Posted on August 4, 2020 (July 14, 2021) by Max Garduño in Uncategorized
• New discovery reveals brain network mechanism that causes spatial memory impairment in Alzheimer’s disease Posted on August 1, 2020 (August 1, 2020) by Max Garduño in Uncategorized
• Interdisciplinary research team awarded $3.8M to study molecular changes in the brain caused by Alzheimer’s disease Posted on June 20, 2020 by Max Garduño in Uncategorized